Snowball logo
logo
4114

Synmosa Biopharma

4114 β€’ TWO
NT$30.00+NT$0.20Β  (0.67%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
3,2354,386.45,140.55,549.56,189.36,369.5
COGS
1,949.62,559.73,020.63,148.63,510.63,640.9
Gross Profit
1,285.41,826.62,119.92,400.92,678.62,728.6
Operating Expenses & Income
Operating Income
185.2455620.3739.1777.9756.6
Total Operating Expenses
3,049.83,931.34,520.24,810.55,411.35,613
R&D Expenses
214.4215.3210.9259.7342.7372.8
Selling General & Admin Expenses
883.61,148.41,286.61,401.91,5581,599.2
Earnings from Continuing Operations
Interest Expense
(51.97)(59.58)(67.26)(58.1)(62.06)(62.62)
Interest Income
2.2324.60511.4114.2719.7520.55
Income Tax Expense
37.81-----
Net Income
Net Income
303.9799.1594.8684.7821.8806.7
Supplemental
EBIT
186.7-----
EBITDA
507.91,105----
In millions of TWD, except % and values per 1 share